Developing long-acting injectable protein therapeutics: challenges, strategies and solutions

Join Innocore's webinar on Developing long-acting Injectable protein therapeutics: challenges, strategies and solutions

With the expanding market for protein therapeutics, there is a growing need for long-acting injectable (LAI) dosage forms that are compatible with biologics. While LAIs offer clear benefits in terms of dosing convenience and patient adherence, formulating proteins into long acting drug products remains challenging due to their structural complexity and susceptibility to degradation.

In this webinar, we will introduce the fundamentals of therapeutic proteins and long acting injectables, discuss the key formulation challenges associated with protein based LAIs, and present how Innocore’s technology is designed to address these challenges.

Through a practical case study, we will demonstrate a structured approach to protein LAI development, focusing on critical aspects such as characterization of protein LAIs, formulation optimization, scalability, and long term stability. The case study will highlight common development challenges encountered in protein LAI programs and illustrate how these challenges can be successfully addressed using an integrated formulation and process development strategy.

The webinar will be presented by Rob Steendam, Co-Founder and CTO of Innocore, and Aiva Simaite, Head of PMO at Innocore.

We will conclude the session with a live Q&A, so feel free to submit your questions throughout the webinar. Register for this free webinar to access all the information with just a click!